Dr. Michael Satlin at Weill Cornell Medicine and Ilana Brito in Ithaca are researching how to fight drug-resistant bacteria – "superbugs" that threaten cancer patients' fragile immune systems.
An experimental drug that blocks the activation of an immune cell component effectively prevented rejection of heart transplants in mice, says new research from scientists at Weill Cornell Medicine.
A Weill Cornell Medicine study published Dec. 7 represents the first time scientists have captured the restoration of communication of a minimally conscious patient by measuring aspects of brain structure and function.
Patients with depression can be categorized into four unique subtypes defined by distinct patterns of abnormal connectivity in the brain, according to new research from Weill Cornell Medicine.
A synthetic mesh commonly used to treat urinary incontinence and weakening of female pelvis walls can lead to complications, new Weill Cornell Medicine research suggests.
A Cornell-led team has devised a method for measuring the mechanical force cells exert on their surroundings, which can help scientists design better biomaterial scaffolds for tissue engineering.
Three faculty members - development economist Chris Barrett, mechanical engineer Sidney Leibovich and medical mycologist Dr. Thomas Walsh - have been named fellows of the American Association for the Advancement of Science.
